Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

April 15, 1997; Volume 158,Issue 8

CUTTING EDGE

  • You have accessRestricted access
    Immune deviation in relation to ocular immune privilege.
    J W Streilein, B R Ksander and A W Taylor
    J Immunol April 15, 1997, 158 (8) 3557-3560;
  • You have accessRestricted access
    Alternate splicing of mouse fusin/CXC chemokine receptor-4: stromal cell-derived factor-1alpha is a ligand for both CXC chemokine receptor-4 isoforms.
    M Heesen, M A Berman, U E Höpken, N P Gerard and M E Dorf
    J Immunol April 15, 1997, 158 (8) 3561-3564;
  • You have accessRestricted access
    A kinase-negative mutation of DNA-PK(CS) in equine SCID results in defective coding and signal joint formation.
    E K Shin, L E Perryman and K Meek
    J Immunol April 15, 1997, 158 (8) 3565-3569;

ARTICLES

  • You have accessRestricted access
    Prethymic CD34+ progenitors capable of developing into T cells are not committed to the T cell lineage.
    B Blom, P Res, E Noteboom, K Weijer and H Spits
    J Immunol April 15, 1997, 158 (8) 3571-3577;
  • You have accessRestricted access
    Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.
    S W Christianson, D L Greiner, R A Hesselton, J H Leif, E J Wagar, I B Schweitzer, T V Rajan, B Gott, D C Roopenian and L D Shultz
    J Immunol April 15, 1997, 158 (8) 3578-3586;
  • You have accessRestricted access
    Antigen processing and presentation by human trophoblast-derived cell lines.
    S J Gobin, L Wilson, V Keijsers and P J Van den Elsen
    J Immunol April 15, 1997, 158 (8) 3587-3592;
  • You have accessRestricted access
    A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state.
    U Grohmann, R Bianchi, E Ayroldi, M L Belladonna, D Surace, M C Fioretti and P Puccetti
    J Immunol April 15, 1997, 158 (8) 3593-3602;
  • You have accessRestricted access
    Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C.
    J P Houchins, L L Lanier, E C Niemi, J H Phillips and J C Ryan
    J Immunol April 15, 1997, 158 (8) 3603-3609;
  • You have accessRestricted access
    Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance.
    Y Ke, K Pearce, J P Lake, H K Ziegler and J A Kapp
    J Immunol April 15, 1997, 158 (8) 3610-3618;
  • You have accessRestricted access
    Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs.
    R Khanna, S R Burrows, S A Thomson, D J Moss, P Cresswell, L M Poulsen and L Cooper
    J Immunol April 15, 1997, 158 (8) 3619-3625;
  • You have accessRestricted access
    CD4+ T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to luminal bacterial antigens.
    U Y Khoo, I E Proctor and A J Macpherson
    J Immunol April 15, 1997, 158 (8) 3626-3634;
  • You have accessRestricted access
    Contribution of CpG motifs to the immunogenicity of DNA vaccines.
    D M Klinman, G Yamshchikov and Y Ishigatsubo
    J Immunol April 15, 1997, 158 (8) 3635-3639;
  • You have accessRestricted access
    CD45RA-RO+ (memory) but not CD45RA+RO- (naive) T cells roll efficiently on E- and P-selectin and vascular cell adhesion molecule-1 under flow.
    A H Lichtman, H Ding, L Henault, G Vachino, R Camphausen, D Cumming and F W Luscinskas
    J Immunol April 15, 1997, 158 (8) 3640-3650;
  • You have accessRestricted access
    Differential contact of disparate class I/peptide complexes as the basis for epitope cross-recognition by a single T cell receptor.
    D J Loftus, Y Chen, D G Covell, V H Engelhard and E Appella
    J Immunol April 15, 1997, 158 (8) 3651-3658;
  • You have accessRestricted access
    IL-2-induced IL-5 synthesis, but not proliferation, of human CD4+ T cells is suppressed by FK506.
    A Mori, M Suko, O Kaminuma, S Inoue, T Ohmura, A Hoshino, Y Asakura, E Terada, K Miyazawa, C Nosaka, Y Okumura, K Ito and H Okudaira
    J Immunol April 15, 1997, 158 (8) 3659-3665;
  • You have accessRestricted access
    Crossregulation between T helper cell (Th)1 and Th2: inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1.
    T B Oriss, S A McCarthy, B F Morel, M A Campana and P A Morel
    J Immunol April 15, 1997, 158 (8) 3666-3672;
  • You have accessRestricted access
    Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF-alpha.
    S L Parry, M Sebbag, M Feldmann and F M Brennan
    J Immunol April 15, 1997, 158 (8) 3673-3681;
  • You have accessRestricted access
    Thymus-independent generation of NK1+ T cells in vitro from fetal liver precursors.
    M Shimamura, T Ohteki, P Launois, A M Garcia and H R MacDonald
    J Immunol April 15, 1997, 158 (8) 3682-3689;
  • You have accessRestricted access
    Calpain, an upstream regulator of thymocyte apoptosis.
    M K Squier and J J Cohen
    J Immunol April 15, 1997, 158 (8) 3690-3697;
  • You have accessRestricted access
    Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DR alpha-chain.
    J Thibodeau, M Dohlsten, I Cloutier, P M Lavoie, P Bjork, F Michel, C Léveillé, W Mourad, T Kalland and R P Sékaly
    J Immunol April 15, 1997, 158 (8) 3698-3704;
  • You have accessRestricted access
    Platelet-activating factor abrogates apoptosis induced by cross-linking of the surface IgM receptor in a human B lymphoblastoid cell line.
    B J Toledano, Y Bastien, F Noya, S Baruchel and B Mazer
    J Immunol April 15, 1997, 158 (8) 3705-3715;
  • You have accessRestricted access
    Bone marrow can function as a lymphoid organ during a primary immune response under conditions of disrupted lymphocyte trafficking.
    R A Tripp, D J Topham, S R Watson and P C Doherty
    J Immunol April 15, 1997, 158 (8) 3716-3720;
  • You have accessRestricted access
    Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles.
    A Valenzuela, J Blanco, C Callebaut, E Jacotot, C Lluis, A G Hovanessian and R Franco
    J Immunol April 15, 1997, 158 (8) 3721-3729;
  • You have accessRestricted access
    MHC class II molecules are required for initiation of positive selection but not during terminal differentiation of human CD4 single positive thymocytes.
    D Vanhecke, B Verhasselt, M De Smedt, B De Paepe, G Leclercq, J Plum and B Vandekerckhove
    J Immunol April 15, 1997, 158 (8) 3730-3737;
  • You have accessRestricted access
    Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor.
    L Van Parijs, A Biuckians, A Ibragimov, F W Alt, D M Willerford and A K Abbas
    J Immunol April 15, 1997, 158 (8) 3738-3745;
  • You have accessRestricted access
    Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells.
    M Vergelli, B Hemmer, M Kalbus, A B Vogt, N Ling, P Conlon, J E Coligan, H McFarland and R Martin
    J Immunol April 15, 1997, 158 (8) 3746-3752;
  • You have accessRestricted access
    Identification of the rat maternally transmitted minor histocompatibility antigen.
    P K Bhuyan, L L Young, K F Lindahl and G W Butcher
    J Immunol April 15, 1997, 158 (8) 3753-3760;
  • You have accessRestricted access
    Human cord blood kappa repertoire.
    A J Feeney, G Lugo and G Escuro
    J Immunol April 15, 1997, 158 (8) 3761-3768;
  • You have accessRestricted access
    Carbohydrate and peptide specificity of MHC class II-restricted T cell hybridomas raised against an O-glycosylated self peptide.
    T Jensen, P Hansen, L Galli-Stampino, S Mouritsen, K Frische, E Meinjohanns, M Meldal and O Werdelin
    J Immunol April 15, 1997, 158 (8) 3769-3778;
  • You have accessRestricted access
    Complement evasion by Echinococcus granulosus: sequestration of host factor H in the hydatid cyst wall.
    A Díaz, A Ferreira and R B Sim
    J Immunol April 15, 1997, 158 (8) 3779-3786;
  • You have accessRestricted access
    Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines.
    E Dufour, G Carcelain, C Gaudin, C Flament, M F Avril and F Faure
    J Immunol April 15, 1997, 158 (8) 3787-3795;
  • You have accessRestricted access
    Nitric oxide and TNF-alpha production by murine peritoneal macrophages activated with a novel 20-kDa protein isolated from Bacillus thuringiensis var. thuringiensis parasporal bodies.
    R Gomez-Flores, C Rodriguez-Padilla, R T Mehta, L Galan-Wong, E Mendoza-Gamboa and R Tamez-Guerra
    J Immunol April 15, 1997, 158 (8) 3796-3799;
  • You have accessRestricted access
    Immunoregulatory idiotypes stimulate T helper 1 cytokine responses in experimental Schistosoma mansoni infections.
    M A Montesano, G L Freeman Jr, W E Secor and D G Colley
    J Immunol April 15, 1997, 158 (8) 3800-3804;
  • You have accessRestricted access
    Mast cell Fc epsilonRI expression in the rat intestinal mucosa and tongue is enhanced during Nippostrongylus brasiliensis infection and can be up-regulated by in vivo administration of IgE.
    N Shaikh, J Rivera, B R Hewlett, R H Stead, F G Zhu and J S Marshall
    J Immunol April 15, 1997, 158 (8) 3805-3812;
  • You have accessRestricted access
    Destruction of follicular dendritic cells during chronic visceral leishmaniasis.
    S C Smelt, C R Engwerda, M McCrossen and P M Kaye
    J Immunol April 15, 1997, 158 (8) 3813-3821;
  • You have accessRestricted access
    Distinct phenotype of leukemic T cells with various tissue tropisms.
    Y Tanaka, A Wake, K J Horgan, S Murakami, M Aso, K Saito, S Oda, I Morimoto, H Uno, H Kikuchi, Y Izumi and S Eto
    J Immunol April 15, 1997, 158 (8) 3822-3829;
  • You have accessRestricted access
    Serum amyloid P component forms a stable complex with human C5b6.
    S F Barbashov, C Wang and A Nicholson-Weller
    J Immunol April 15, 1997, 158 (8) 3830-3835;
  • You have accessRestricted access
    Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun.
    C Brostjan, J Anrather, V Csizmadia, G Natarajan and H Winkler
    J Immunol April 15, 1997, 158 (8) 3836-3844;
  • You have accessRestricted access
    Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages.
    A Habib, C Bernard, M Lebret, C Creminon, B Esposito, A Tedgui and J Maclouf
    J Immunol April 15, 1997, 158 (8) 3845-3851;
  • You have accessRestricted access
    Complement-inhibiting peptides identified by proximity to indels in the C3/4/5 protein family.
    R T Ogata and P J Low
    J Immunol April 15, 1997, 158 (8) 3852-3860;
  • You have accessRestricted access
    TNF-alpha, unlike other pro- and anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells.
    S Orlando, C Matteucci, E J Fadlon, W A Buurman, M T Bardella, F Colotta, M Introna and A Mantovani
    J Immunol April 15, 1997, 158 (8) 3861-3868;
  • You have accessRestricted access
    Constitutive shedding of both p55 and p75 murine TNF receptors in vivo.
    J K Pinckard, K C Sheehan, C D Arthur and R D Schreiber
    J Immunol April 15, 1997, 158 (8) 3869-3873;
  • You have accessRestricted access
    Lipopolysaccharide induces synthesis of mouse colony-stimulating factor-1 in vivo.
    P Roth, A Bartocci and E R Stanley
    J Immunol April 15, 1997, 158 (8) 3874-3880;
  • You have accessRestricted access
    Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II.
    P Ruggiero, P Bossù, G Macchia, E Del Grosso, V Sabbatini, R Bertini, A Colagrande, C Bizzarri, G Maurizi, V Di Cioccio, G D'Andrea, A Di Giulio, F Frigerio, R Grifantini, G Grandi, A Tagliabue and D Boraschi
    J Immunol April 15, 1997, 158 (8) 3881-3887;
  • You have accessRestricted access
    Neutrophil-activating protein ENA-78 and IL-8 exhibit different patterns of expression in lipopolysaccharide- and cytokine-stimulated human monocytes.
    S Schnyder-Candrian and A Walz
    J Immunol April 15, 1997, 158 (8) 3888-3894;
  • You have accessRestricted access
    Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells.
    P Schratzberger, N Reinisch, W M Prodinger, C M Kähler, B A Sitte, R Bellmann, R Fischer-Colbrie, H Winkler and C J Wiedermann
    J Immunol April 15, 1997, 158 (8) 3895-3901;
  • You have accessRestricted access
    Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia.
    H U Simon, S Yousefi, C Schranz, A Schapowal, C Bachert and K Blaser
    J Immunol April 15, 1997, 158 (8) 3902-3908;
  • You have accessRestricted access
    Intracellular localization of the human receptor for the globular domains of C1q.
    R H van den Berg, F Prins, M C Faber-Krol, N J Lynch, W Schwaeble, L A van Es and M R Daha
    J Immunol April 15, 1997, 158 (8) 3909-3916;
  • You have accessRestricted access
    Chemokines are expressed in a myeloid cell-dependent fashion and mediate distinct functions in immune complex glomerulonephritis in rat.
    X Wu, G J Dolecki, B Sherry, J Zagorski and J B Lefkowith
    J Immunol April 15, 1997, 158 (8) 3917-3924;
  • You have accessRestricted access
    Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid.
    M M Wurfel and S D Wright
    J Immunol April 15, 1997, 158 (8) 3925-3934;
  • You have accessRestricted access
    Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit.
    L C Agren, L Ekman, B Löwenadler and N Y Lycke
    J Immunol April 15, 1997, 158 (8) 3936-3946;
  • You have accessRestricted access
    Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes.
    J D Ahlers, N Dunlop, D W Alling, P L Nara and J A Berzofsky
    J Immunol April 15, 1997, 158 (8) 3947-3958;
  • You have accessRestricted access
    Endotoxin and IL-1 hyporesponsiveness in a patient with recurrent bacterial infections.
    D B Kuhns, D A Long Priel and J I Gallin
    J Immunol April 15, 1997, 158 (8) 3959-3964;
  • You have accessRestricted access
    Biologic properties of a bispecific single-chain antibody directed against 17-1A (EpCAM) and CD3: tumor cell-dependent T cell stimulation and cytotoxic activity.
    M Mack, R Gruber, S Schmidt, G Riethmüller and P Kufer
    J Immunol April 15, 1997, 158 (8) 3965-3970;
  • You have accessRestricted access
    Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration.
    D Pajkrt, L Camoglio, M C Tiel-van Buul, K de Bruin, D L Cutler, M B Affrime, G Rikken, T van der Poll, J W ten Cate and S J van Deventer
    J Immunol April 15, 1997, 158 (8) 3971-3977;
  • You have accessRestricted access
    Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent.
    D V Serreze, H D Chapman, D S Varnum, I Gerling, E H Leiter and L D Shultz
    J Immunol April 15, 1997, 158 (8) 3978-3986;
  • You have accessRestricted access
    Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets.
    S Songia, A Mortellaro, S Taverna, C Fornasiero, E A Scheiber, E Erba, F Colotta, A Mantovani, A M Isetta and J Golay
    J Immunol April 15, 1997, 158 (8) 3987-3995;
  • You have accessRestricted access
    HIV-induced T cell syncytia are self-perpetuating and the primary cause of T cell death in culture.
    A Sylwester, S Murphy, D Shutt and D R Soll
    J Immunol April 15, 1997, 158 (8) 3996-4007;
  • You have accessRestricted access
    Enhancement of cell-mediated immunity against HIV-1 induced by coinnoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12.
    T Tsuji, K Hamajima, J Fukushima, K Q Xin, N Ishii, I Aoki, Y Ishigatsubo, K Tani, S Kawamoto, Y Nitta, J Miyazaki, W C Koff, T Okubo and K Okuda
    J Immunol April 15, 1997, 158 (8) 4008-4013;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 158, Issue 8
15 Apr 1997
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • CUTTING EDGE
  • ARTICLES
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606